What's in Peter MacCallum Cancer Centre, Australia's pipeline?

Peter MacCallum Cancer Centre, Australia has 12 drugs in our index: 0 marketed, 0 filed, 0 in Phase 3, 5 in Phase 2, 7 in Phase 1.

Which companies overlap with Peter MacCallum Cancer Centre, Australia's portfolio?

Top competitors by shared drug class: Ain Shams University, Chinese PLA General Hospital, Federation Francophone de Cancerologie Digestive, Hoffmann-La Roche, Japan Clinical Oncology Group.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/peter-maccallum-cancer-centre-australia.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Peter MacCallum Cancer Centre, Australia — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Peter MacCallum Cancer Centre, Australia pipeline: 0 marketed, 0 filed, 0 Phase 3, 5 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 0 Phase 3 5 Phase 2 7 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

No leading-phase drugs tracked for this sponsor.

Therapeutic area mix

Oncology · 2
Oncology, Hematology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Ain Shams University · 1 shared drug class
Chinese PLA General Hospital · 1 shared drug class
Federation Francophone de Cancerologie Digestive · 1 shared drug class
Hoffmann-La Roche · 1 shared drug class
Japan Clinical Oncology Group · 1 shared drug class
Jiangxi Provincial Cancer Hospital · 1 shared drug class
National Cancer Center, Korea · 1 shared drug class
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Peter MacCallum Cancer Centre, Australia:

Cite this brief

Drug Landscape (2026). Peter MacCallum Cancer Centre, Australia — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/peter-maccallum-cancer-centre-australia. Accessed 2026-05-16.